Results 91 to 100 of about 82,830 (185)

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients

open access: yesJHLT Open
Antifungal prophylaxis postheart transplant (HT) may include voriconazole or clotrimazole, which interact with tacrolimus. There is no guidance for tacrolimus adjustment when transitioning from voriconazole to clotrimazole; therefore, this study ...
Elizabeth Posney, PharmD   +3 more
doaj   +1 more source

CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation

open access: yes, 2018
Eunhee Ji,1,* Myeong Gyu Kim,2,* Jung Mi Oh3 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gachon University, Incheon 21936, Republic of Korea; 2Graduate School of Clinical Pharmacy, CHA University, Pocheon 11160, Republic of ...
Oh JM, Ji E, Kim MG
core  

Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients

open access: yes, 2018
Ho Joong Choi, Dong Goo Kim, Bong Jun Kwak, Jae Hyun Han, Tae Ho Hong, Young Kyoung You Department of Surgery, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea Introduction: The purpose of ...
Kim DG   +5 more
core  

Tacrolimus (fk506) et interactions médicamenteuses

open access: yes, 1997
Tacrolimus, a new immunosuppressive drug, possess similar pharmacokinetic and pharmacodynamic properties in many drug interactions, it is logical to chink that tacrolimus is also involved in different drug interactions. The aim of the present paper is to
Pauwels, Olivier
core  

Topical Tacrolimus in Vitiligo: Consensus Paper from the Pigmentary Disorders Society [PDF]

open access: yes
Rashmi Sarkar,1 Sunil Dogra,2 Keshavamurthy Vinay,2 Surabhi Sinha,3 Vignesh R Narayan,4 Muthu Sendhil Kumaran,2 Indrashis Podder,5 Soumya Jagadeesan,6 Mala Bhalla,7 Anupam Das,8 Ridhima Lakhani,9 Richa Sharma,10 Shyamanta Barua,11 Vijay K Somani,12 D M ...
Jagadeesan S   +16 more
core  

Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes

open access: yes
Thi Van Anh Nguyen,1,* Ba Hai Le,2,* Minh Thanh Nguyen,2,* Viet Thang Le,3,* Viet Tien Tran,4,* Dinh Tuan Le,5,* Duong Anh Minh Vu,2,* Quy Kien Truong,3,* Trong Hieu Le,2,* Huong Thi Lien Nguyen2,* 1Department of ...
Le BH   +9 more
core  

Update on the clinical utility of once-daily tacrolimus in the management of transplantation

open access: yes, 2015
Jane Revollo Department of Pharmacy, Jackson Memorial Hospital, University of Miami Leonard M Miller School of Medicine Miami, FL, USAThe review by Posadas Salas and Srinivas of the clinical utility of once-daily tacrolimus formulations in the ...
Revollo J
core  

Extended-Release Tacrolimus Versus LifeCycle Pharma Tacrolimus in Kidney Transplant Recipients: A Switch Study

open access: yes
Background: Tacrolimus is a first-line immunosuppressant used in kidney transplantation. However, its narrow therapeutic window and variable exposure present challenges.
Liffert Vogt   +10 more
core   +1 more source

Tacrolimus Optic Neuropathy

open access: yes, 2018
Tacrolimus (FK506, Prograf) is a potent immunosuppressant, which inhibits cytokine synthesis and blocks T-cell development. Optic neuropathy from tacrolimus toxicity is very uncommon but, when present, can result in severe vision loss.
Nailyn Rasool, MD, FRCPC; Katherine Boudreault, MD, FRCSC; Simmons Lessell, MD; Sashank Prasad, MD; Dean M. Cestari, MD
core  

Interaction Between Tacrolimus and Clindamycine

open access: yes, 2010
Tacrolimus is being increasingly used as an immunosuppressive agent in transplant recipients. The drug is metabolized by the cytochrome P-450 3A system, thus antimicrobials that inhibit or induce these enzymes can alter levels of tacrolimus in the ...
Castanares Zapatero, Diego   +4 more
core  

Home - About - Disclaimer - Privacy